510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K880762Substantially Equivalent

Taper Flex-Tip Steerable Guidewire

Target Therapeutics, Los Angeles CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K880762 is the FDA 510(k) clearance record for TAPER FLEX-TIP STEERABLE GUIDEWIRE, a class II device, cleared for Target Therapeutics on under FDA product code DQX (Wire, Guide, Catheter). FDA records list 70 510(k) clearances for Target Therapeutics, from to . As of , FDA records show no recalls naming K880762.

Clearance record

Decision date
Received
(176 days to decision)
Product code
DQX Wire, Guide, Catheter
Regulation
21 CFR 870.1330
Device class
Class II
Review panel
Cardiovascular
Applicant
Target Therapeutics 2100 S. Sepulveda Blvd., Los Angeles CA
Third party review
No

Clearances, product code DQX

Trailing 12 months
12 clearances under product code DQX in the twelve months to October 2026, January 2026 the highest month at 3.
Show the numbers
Monthly 510(k) clearances under FDA product code DQX, trailing twelve months
MonthClearances
November 20251
December 20250
January 20263
February 20260
March 20263
April 20260
May 20261
June 20260
July 20262
August 20260
September 20262
October 20260